TIBET PHARMACEUTICALS, INC.
CIK 0001489077
Revenue (TTM)
$34.19M
Q3 Sep 2011
Net Income (TTM)
$12.4M
Q3 Sep 2011
EPS Diluted (TTM)
—
Q3 Sep 2011
Gross Margin
45.5%
Q3 Sep 2011
Operating Margin
36.3%
Q3 Sep 2011
Net Margin
36.3%
Q3 Sep 2011
Free Cash Flow (TTM)
—
Q3 Sep 2011
Cash
$25.96M
Q3 Sep 2011
Total Debt
—
Q3 Sep 2011
Shares Outstanding
14.85M sh
Q3 Sep 2011